Spectral Medical Inc., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEDI. From 23 October 2025 to 23 October 2026, the disclosure feed for Spectral Medical Inc. logged 23 filings by 8 insiders.
There is no open-market purchase to report; the filings show 3 sales worth €472k by 2 insiders. At €200k, the sale published on 27 January 2026 by Kellum, John is the largest of the period.
Typically, a trade is published a median of 5 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
Across the 2,472 companies tracked on its exchange, the median is 13 filings; at 23 filings, this issuer sits above that mark. The full history, which starts in 2016, counts 19 purchases against 27 sales.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2025 · cache
25 of 134 declarations
Spectral Medical Inc. is a Canadian company focused on developing treatments for severe diseases, including sepsis. It is listed on the Toronto Stock Exchange under the symbol XTSE.
Insider filings
Over the last 90 days, 14 filings published between 16 July and 6 October 2026: 2 sales for EUR 272,638. 12 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers). Largest amounts: Seto, Chris (5 - Senior Officer of Issuer), sales of EUR 272,638.
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 13 October 2026 (UTC)